Related content

Endocrinology. Follicular and luteal phase characteristics following early cessation of gonadotrophin-releasing hormone agonist during ovarian stimulation for in-vitro fertilization

By Beckers N.G.M.  

Human Reproduction, Vol. 15, Iss. 1, 2000-01 ,pp. : 43-49

Oxford University Press

Access to resources Recommend Favorite

Vascular endothelial growth factor in serum and in the follicular fluid of patients undergoing hormonal stimulation for in-vitro fertilization

By Moncayo HE  

Human Reproduction, Vol. 13, Iss. 12, 1998-12 ,pp. : 3310-3314

Oxford University Press

Access to resources Recommend Favorite

Endocrinology. Adjuvant L-arginine treatment for in-vitro fertilization in poor responder patients

By Battaglia C.  

Human Reproduction, Vol. 14, Iss. 7, 1999-07 ,pp. : 1690-1697

Oxford University Press

Access to resources Recommend Favorite

Increase in transforming growth factor β1 in ovarian follicular fluid following ovarian stimulation and in-vitro fertilization correlates to pregnancy

By Fried G   Wramsby H  

Human Reproduction, Vol. 13, Iss. 3, 1998-03 ,pp. : 656-659

Oxford University Press

Access to resources Recommend Favorite

Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients

By Damario M.A.   Barmat L.   Liu H.-C.   Davis O.K.   Rosenwaks Z.  

Human Reproduction, Vol. 12, Iss. 11, 1997-11 ,pp. : 2359-2365

Oxford University Press

Access to resources Recommend Favorite